Rapport Therapeutics shares owned by Eventide Asset Management
Quarter-by-quarter ownership of Rapport Therapeutics shares owned by Eventide Asset Management
from 13F filings
Historical chart of Eventide Asset Management investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Eventide Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.2M | 50k | 23.26 |